Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full – 2012) http://onlinelibrary.wiley.com/doi/1...12.02042.x/pdf
Cannabinoid receptor CB2 protects against balloon-induced neointima formation (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774259/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full – 2013) http://www.jlr.org/content/early/201...r.M035147.long
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924
Cannabinoid receptor CB2 protects against balloon-induced neointima formation (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774259/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full – 2013) http://www.jlr.org/content/early/201...r.M035147.long
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924